Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading KERX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.46%73.760.9%$699.22m
AMGNAmgen Inc.
0.50%180.211.1%$562.99m
CELGCelgene Corporation
1.05%137.741.1%$511.41m
REGNRegeneron Pharmaceuticals, Inc.
-1.00%515.922.7%$478.88m
VRTXVertex Pharmaceuticals Incorporated
2.41%163.171.9%$401.70m
BIIBBiogen Inc.
0.53%282.921.2%$362.26m
ALXNAlexion Pharmaceuticals, Inc.
1.53%131.791.9%$271.34m
TSROTESARO, Inc.
2.29%131.9714.7%$172.59m
ILMNIllumina, Inc.
0.45%172.753.5%$161.08m
INCYIncyte Corporation
0.32%134.222.6%$151.82m
EXELExelixis, Inc.
0.89%27.236.5%$148.60m
CLVSClovis Oncology, Inc.
1.61%86.6418.0%$130.90m
BMRNBioMarin Pharmaceutical Inc.
1.76%89.284.4%$127.08m
KITEKite Pharma, Inc.
-0.67%109.1516.1%$120.98m
SRPTSarepta Therapeutics, Inc.
6.06%43.4119.8%$112.50m

Company Profile

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.